SUN PHARMACEUTICAL INDUSTRIES

The current price of SUNPHARMA is 1519.25 INR — it has decreased by 1.15% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SUN PHARMACEUTICAL INDUSTRIES stocks are traded under the ticker SUNPHARMA.

SUN PHARMACEUTICAL INDUSTRIES is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for SUN PHARMACEUTICAL INDUSTRIES has a max estimate of 1827.00 INR and a min estimate of 1200.00 INR.

SUNPHARMA earnings for the last quarter are 9.90 INR whereas the estimation was 8.98 INR which accounts for 10.24% surprise. Estimated earnings for the next quarter are 9.95 INR. See more details about SUN PHARMACEUTICAL INDUSTRIES earnings.

Yes, you can track SUN PHARMACEUTICAL INDUSTRIES financials in yearly and quarterly reports right on TradingView.

SUNPHARMA stock has fallen by 5.59% compared to the previous week, the month change is a 3.70% fall, over the last year SUN PHARMACEUTICAL INDUSTRIES has showed a 52.46% increase.

Like other stocks, SUNPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMACEUTICAL INDUSTRIES stock right from TradingView charts — choose your broker and connect to your account.

SUNPHARMA reached its all-time high on Apr 5, 2024 with the price of 1638.70 INR, and its all-time low was 26.00 INR and was reached on Oct 30, 2003.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has ‪24.77 K‬ employees. See our rating of the largest employees — is SUN PHARMACEUTICAL INDUSTRIES on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMACEUTICAL INDUSTRIES EBITDA is ‪127.25 B‬ INR, and current EBITDA margin is 26.52%. See more stats in SUN PHARMACEUTICAL INDUSTRIES financial statements.